Funds holding Tanvex BioPharma Inc
ISIN KYG8676P1037 · Cayman Islands
- Fund holders
- 6
- Of which ETFs
- 3 3 other funds
- Value held
- 358.2K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 82,000 | 94.6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 79,000 | 99.4K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 47,000 | 53.9K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 38,000 | 43.6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 33,000 | 38.1K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 25,000 | 28.7K $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Jun 30, 2026 ↗ |
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 6 | +5 | 304,000 | +284.8 % |
| 2026Q2 | 1 | 0 | 79,000 | 0.0 % |
| 2026Q1 | 1 | 0 | 79,000 | +64.6 % |
| 2025Q4 | 1 | 0 | 48,000 | +92.0 % |
| 2025Q2 | 1 | 0 | 25,000 | -79.6 % |
| 2024Q3 | 1 | 0 | 122,632 | +17.9 % |
| 2024Q2 | 1 | 0 | 104,000 | 0.0 % |
| 2024Q1 | 1 | 0 | 104,000 | 0.0 % |
| 2023Q4 | 1 | 104,000 |
Cite this page
Titelia. "Funds holding Tanvex BioPharma Inc". https://titelia.com/en/stocks/tanvex-biopharma-inc-KYG8676P1037